Carmell Therapeutics Corporation (CTCX) — Cash Flow Quality Index

Latest as of December 2024: -0.07x

Carmell Therapeutics Corporation (CTCX) has a Cash Flow Quality Index of -0.07x as of December 2024. Operating cash flow of $-772.06K is below net income of $10.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Carmell Therapeutics Corporation to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.07x

Operating CF / Net Income

Operating Cash Flow

$-772.06K

USD

Net Income

$10.84 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Carmell Therapeutics Corporation (None–None)

Year-by-year earnings quality comparison for Carmell Therapeutics Corporation. For live market cap and the full company financial profile, see CTCX market cap.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.